Department of Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Pediatr Pulmonol. 2021 Dec;56(12):3644-3656. doi: 10.1002/ppul.25647. Epub 2021 Sep 15.
In this study, the spectrum and frequency of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations previously reported among Iranian cystic fibrosis (CF) patients have been reviewed and discussed. Using the keywords of Cystic Fibrosis, CF, CFTR, and Iran, along with their Persian equivalents, a comprehensive search was performed on the online databases. After applying the inclusion and exclusion criteria, 16 articles with an overall sample of 735 Iranian patients with CF, were included in this systematic review. A total of 101 different CFTR gene variants had been reported. The mutation of p.Phe508del (c.1521_1523delCTT) (21.22%) was the most frequent one among Iranian patients with CF. In conclusion, due to the fact that in many provinces of Iran no specific study has been done so far, it seems that the CFTR gene mutation spectrum in patients with CF from Iran is much wider.
在这项研究中,回顾和讨论了先前在伊朗囊性纤维化 (CF) 患者中报告的囊性纤维化跨膜电导调节因子 (CFTR) 基因突变的谱和频率。使用关键词囊性纤维化、CF、CFTR 和伊朗,以及它们的波斯语等效词,在在线数据库上进行了全面搜索。在应用纳入和排除标准后,这项系统评价纳入了 16 篇文章,共涉及 735 名伊朗 CF 患者的总体样本。共报告了 101 种不同的 CFTR 基因突变。p.Phe508del (c.1521_1523delCTT) 突变(21.22%)是伊朗 CF 患者中最常见的突变。总之,由于到目前为止,伊朗许多省份尚未进行具体研究,因此伊朗 CF 患者的 CFTR 基因突变谱似乎更为广泛。